Sandbox Reserved 1087
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
In Gram-negative bacteria, such as Escherichia coli, one of the main reasons behind bacterial multidrug resistance is resistance nodulation cell division (RND) transporters which pump a wide range of dyes, bile salts, detergents and structurally unrelated antibiotics out of the cell by proton motive force driven efflux. The natural function of the efflux system is currently under debate. AcrB is the major RND transporter in E. coli. Three proteins form the tripartite multidrug efflux system that pumps the drugs out from the cell. The AcrB transporter, the inner membrane component of the system, cooperates with two other proteins: membrane fusion protein AcrA and an outer membrane channel TolC. The TolC component is connected to outer membrane and AcrB is connected to the inner membrane. The AcrA connects TolC and AcrB together (Fig 1). The structure of the complex indicates that the drugs are transported out of the cell in a three-step procedure.<ref name= "Nakashima">PMID: 12607261</ref><ref name= "Klaas">PMID: 19166984</ref><ref name= "Murasaki">PMID: 18644451</ref> | In Gram-negative bacteria, such as Escherichia coli, one of the main reasons behind bacterial multidrug resistance is resistance nodulation cell division (RND) transporters which pump a wide range of dyes, bile salts, detergents and structurally unrelated antibiotics out of the cell by proton motive force driven efflux. The natural function of the efflux system is currently under debate. AcrB is the major RND transporter in E. coli. Three proteins form the tripartite multidrug efflux system that pumps the drugs out from the cell. The AcrB transporter, the inner membrane component of the system, cooperates with two other proteins: membrane fusion protein AcrA and an outer membrane channel TolC. The TolC component is connected to outer membrane and AcrB is connected to the inner membrane. The AcrA connects TolC and AcrB together (Fig 1). The structure of the complex indicates that the drugs are transported out of the cell in a three-step procedure.<ref name= "Nakashima">PMID: 12607261</ref><ref name= "Klaas">PMID: 19166984</ref><ref name= "Murasaki">PMID: 18644451</ref> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Line 36: | Line 26: | ||
'''<scene name='70/700000/Tolc_docking/1'>TolC docking domain</scene>''' | '''<scene name='70/700000/Tolc_docking/1'>TolC docking domain</scene>''' | ||
| - | The TolC docking domain, located in the periplasm, has two subdomains: <scene name='70/700000/Acrb_dn/1'>DN</scene> and <scene name='70/700000/Acrb_dc/1'>DC</scene>. The subdomains contain a four-stranded mixed | + | The TolC docking domain, located in the periplasm, has two subdomains: <scene name='70/700000/Acrb_dn/1'>DN</scene> and <scene name='70/700000/Acrb_dc/1'>DC</scene>. The subdomains contain a four-stranded mixed β-sheet. The TolC domain forms a funnel-like structure that has a similar diameter as the bottom of TolC. The TolC docking domain of AcrB and the bottom of TolC fits well with each other for connecting.<ref name= "Nakashima"/> |
'''<scene name='70/700000/Pore_domain/1'>Pore domain </scene>''' | '''<scene name='70/700000/Pore_domain/1'>Pore domain </scene>''' | ||
| - | The pore domain consists of subdomains <scene name='70/700000/Acrb_pn1/1'>PN1</scene>, <scene name='70/700000/Acrb_pn2/1'>PN2</scene>, <scene name='70/700000/Acrb_pc1/1'>PC1</scene> and <scene name='70/700000/Acrb_pc2/1'>PC2</scene> (Fig. 3A). These subdomains have a characteristic structural motif: two | + | The pore domain consists of subdomains <scene name='70/700000/Acrb_pn1/1'>PN1</scene>, <scene name='70/700000/Acrb_pn2/1'>PN2</scene>, <scene name='70/700000/Acrb_pc1/1'>PC1</scene> and <scene name='70/700000/Acrb_pc2/1'>PC2</scene> (Fig. 3A). These subdomains have a characteristic structural motif: two β-strand–α-helix–β-strand motifs are directly repeated and sandwiched with each other. This motif forms a structure in which two α-helices are located on a four-stranded antiparallel β-sheet. Three α-helices from each PN1 subdomains form a pore in the middle of the structure (Fig. 3B). The pore connects with the bottom of the funnel-like structure of the TolC domain. The extramembrane part of the central membrane hole, namely, the central cavity is present at the proximal end of the central pore (Fig. 2c). Between PN2 and PC2, there are vestibules open at the side of the pore domain into the periplasm (Fig. 3B). They have access to the central cavity. Analysis with the AcrA has suggested that PC1 and PC2 subdomains play a role in attaching the AcrA to the complex. Studies have suggested that C-terminal domain residues <scene name='70/700000/Acrb_290-357/1'>290-357</scene> play a major role in interacting with AcrA.<ref name= "Nakashima"/><ref name= "Klaas"/> |
| Line 54: | Line 44: | ||
[[Image:Nature01050-f5.2.jpg|thumb|right|350px|Figure 4. Proposed model of the AcrB/AcrA/TolC complex and the schematic mechanism of multidrug export mediated by AcrAB/TolC system<ref name= "Nakashima"/>]] | [[Image:Nature01050-f5.2.jpg|thumb|right|350px|Figure 4. Proposed model of the AcrB/AcrA/TolC complex and the schematic mechanism of multidrug export mediated by AcrAB/TolC system<ref name= "Nakashima"/>]] | ||
| - | Possible mechanism of transport function has been postulated. ArcB can cooperate with TolC in the TolC docking domain forming a direct pathway from the cytoplasm to the extracellular milieu. Based on the information of structure, there might be two pathways for the substrate translocation to the cavity. One is the groove located between TM8 and TM7 in the transmembrane domain of each monoter (Fig 1C). The other is the vestibules which are between PN2 and PC2 of the pore domains. The substrates located in the inner leaflet of the membrane and cytoplasm would get access to the cavity through the transmembrane groove, while the substrates that are on the outer space or in the outer leaflet of the membrane are more likely to be transported to the cavity through the vestibules.<ref name= "Nakashima"/> | + | Possible mechanism of transport function has been postulated. ArcB can cooperate with TolC in the TolC docking domain forming a direct pathway from the cytoplasm to the extracellular milieu. Based on the information of structure, there might be two pathways for the substrate translocation to the central cavity. One is the groove located between TM8 and TM7 in the transmembrane domain of each monoter (Fig 1C). The other is the vestibules which are between PN2 and PC2 of the pore domains. The substrates located in the inner leaflet of the membrane and cytoplasm would get access to the central cavity through the transmembrane groove, while the substrates that are on the outer space or in the outer leaflet of the membrane are more likely to be transported to the cavity through the vestibules.<ref name= "Nakashima"/> |
Studies have been done on the substrate binding and specificity and the periplasmic part of the tripartite efflux system is found important to the substrate specificity. In the study on antibiotics to AcrB, Phe<scene name='70/700000/Acrb_386/1'>386</scene> (TM3) was reported as one the main hydrophobic contacts. However, currently, the theoretical explanation of the wide variety of substrates is still lacking.<ref name= "Nakashima"/> | Studies have been done on the substrate binding and specificity and the periplasmic part of the tripartite efflux system is found important to the substrate specificity. In the study on antibiotics to AcrB, Phe<scene name='70/700000/Acrb_386/1'>386</scene> (TM3) was reported as one the main hydrophobic contacts. However, currently, the theoretical explanation of the wide variety of substrates is still lacking.<ref name= "Nakashima"/> | ||
| - | The tripartite efflux system coupled with proton-motive force across the cytoplasmic membrane. It is the binding and release of protons in the transmembrane domain that is crucial to the energy transduction.<ref name= "Klaas"/> Certain key residues had been identified as crucial to the protons translocation. They are the residues Lys940 (TM10) and Asp407 and 408 (TM4) harbored in <scene name='70/700000/Acrb_tm_4/2'>TM4</scene> and <scene name='70/700000/Acrb_tm10/2'>TM10</scene> in each monomer. When the ion pairs between them are disrupted due to the transient protonation of residues mentioned above, there may be conformational change of TM 4 and | + | The tripartite efflux system coupled with proton-motive force across the cytoplasmic membrane. It is the binding and release of protons in the transmembrane domain that is crucial to the energy transduction.<ref name= "Klaas"/> Certain key residues had been identified as crucial to the protons translocation. They are the residues Lys940 (TM10) and Asp407 and 408 (TM4) harbored in <scene name='70/700000/Acrb_tm_4/2'>TM4</scene> and <scene name='70/700000/Acrb_tm10/2'>TM10</scene> in each monomer. When the ion pairs between them are disrupted due to the transient protonation of residues mentioned above, there may be conformational change of TM 4 and TM10. Through possible remote conformational coupling, the conformational change of TM 4 and TM10 may induce the opening of the pore.<ref name= "Nakashima"/> |
Revision as of 20:30, 23 April 2015
| |||||||||||
